Today: 17 May 2026
AMD stock steadies before the open after Meta AI chip deal, 160 mln-share warrant

AMD stock steadies before the open after Meta AI chip deal, 160 mln-share warrant

New York, February 25, 2026, 04:56 (ET) — Premarket

  • AMD edged higher in premarket trading, following its 8.8% surge from the previous session.
  • The Meta agreement features a performance-based warrant, contingent on both shipment milestones and specific stock-price targets.
  • Nvidia steps into the spotlight later Wednesday, with chip investors watching closely for signals on demand.

Advanced Micro Devices, Inc. shares edged up in premarket trading Wednesday, after the chipmaker disclosed a multi-year artificial intelligence chip supply agreement with Meta Platforms. The arrangement could end up giving the Facebook parent a significant equity stake.

The deal drops as AI hardware stocks twitch, investors pushing hard for proof that data-center chip demand can actually stretch beyond just a single dominant player.

Nvidia is set to report results in just a few hours—a regular catalyst that tends to swing the entire sector and can swiftly shift how investors look at spending around AI servers and accelerators.

AMD edged 0.4% higher to $214.78 in premarket moves, following a sharp 8.77% jump Tuesday that left shares finishing at $213.84. The prior session saw AMD swing between $206.50 and $216.71, with volume near 81 million shares.

AMD on Tuesday announced a deal to supply Meta with up to $60 billion worth of AI chips over five years, handing Meta the right to snap up as much as a 10% stake in AMD. “Locking in supply, diversifying away from a single vendor,” said Matt Britzman, senior equity analyst at Hargreaves Lansdown—echoing Big Tech’s scramble for hard-to-get processors. Reuters

AMD’s first rollout features a custom Instinct GPU built on the MI450 architecture, paired with its sixth-generation EPYC “Venice” server CPUs and ROCm software, all part of the company’s Helios rack-scale system. CEO Lisa Su pointed to Meta’s plans to “push the boundaries of AI at unprecedented scale.” Mark Zuckerberg, Meta’s CEO, said the collaboration allows Meta to “diversify our compute.” CFO Jean Hu told reporters the deal is set to “drive substantial multi-year revenue growth.” AMD

According to a securities filing, Meta holds a warrant allowing it to buy as many as 160 million AMD shares at just $0.01 apiece. The vesting? It depends on hitting certain shipment milestones—specifically, up to six gigawatts of Instinct GPU purchases—as well as AMD’s stock hitting price targets that reach $600 for the last tranche. Meta can exercise the option through Feb. 23, 2031, and also secured registration rights for these shares, the filing noted.

Meta’s angle here is inference—the point when an AI model spits out user responses—a process that quickly shines a spotlight on cost and energy efficiency as usage climbs. AMD, for its part, is pushing the idea that the hardware isn’t everything: custom systems and software count, too, and buyers get on board early if they trust the roadmap.

Even so, the setup isn’t one-sided. The warrant acts like a bargain share—assuming milestones come through. But there’s plenty for investors to scrutinize: dilution, tangled performance hurdles, and the reliability of those delivery timelines, especially as the AI scramble grows more chaotic.

Nvidia’s report lands later Wednesday, a key gauge for traders sizing up AI chip demand and pricing dynamics. Details on Meta’s buying pace, along with how swiftly AMD can deliver MI450-based systems, look set to dictate AMD’s trajectory from here.

Stock Market Today

  • Dynatrace Shares Drop 13% on Slower Sales Growth Forecast
    May 17, 2026, 4:27 AM EDT. Shares of cloud observability platform Dynatrace (NYSE: DT) dropped 13.1% after management projected a slowdown in quarterly sales growth to 15% from 19.4%. Despite reporting first-quarter adjusted earnings of $0.41 per share and revenue of $531.7 million, both above analyst estimates, the company's weaker next-quarter guidance weighed on investor sentiment. The earnings forecast was slightly ahead for the full year, but quarterly earnings per share guidance missed consensus. Dynatrace shares have fallen 20.6% year-to-date and trade 40.6% below their 52-week high of $56.64. The recent volatility contrasts with broader software sector strength fueled by positive forecasts from peers like Atlassian and Twilio.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 17.05.2026

17 May 2026
LIVEMarkets rolling coverageStarted: May 17, 2026, 4:00 AM EDTUpdated: May 17, 2026, 4:31 AM EDT Dynatrace Shares Drop 13% on Slower Sales Growth Forecast May 17, 2026, 4:27 AM EDT. Shares of cloud observability platform Dynatrace (NYSE: DT) dropped 13.1% after management projected a slowdown in quarterly sales growth to 15% from 19.4%. Despite reporting first-quarter adjusted earnings of $0.41 per share and revenue of $531.7 million, both above analyst estimates, the company’s weaker next-quarter guidance weighed on investor sentiment. The earnings forecast was slightly ahead for the full year, but quarterly earnings per share guidance missed consensus. Dynatrace shares
Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Shares Slide After Record Revenue, Market Looks to Next INFQ Catalyst

Infleqtion Shares Slide After Record Revenue, Market Looks to Next INFQ Catalyst

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Tokyo stock market today: Nikkei hits new record as yen weakens and AI jitters ease
Previous Story

Tokyo stock market today: Nikkei hits new record as yen weakens and AI jitters ease

MercadoLibre stock set for a rough open after profit miss and margin squeeze hits MELI
Next Story

MercadoLibre stock set for a rough open after profit miss and margin squeeze hits MELI

Go toTop